Showing 541-550 of 993 results for "".
- Galderma to Participate in New York's PrideFest Sundayhttps://modernaesthetics.com/news/galderma-to-participate-in-new-yorks-pridefest-sunday/2473261/Galderma is participating in New York City's official LGBTQIA+ Pride (NYC Pride) event. This month marks the official launch of Restylane's "XpresYourself" communications campaign, which gives a nod to Restylane's XpresHAn Technology™, a u
- Katie Glowski Joins Living Proof as Chief Sales Officerhttps://modernaesthetics.com/news/katie-glowski-joins-living-proof-as-chief-sales-officer/2473258/Katie Glowski is now Chief Sales Officer at Living Proof. She has more than 25 years of brand management and sales experience across integrated marketing, sales strategy, financial operations, and talent development. “I am thrilled to join the
- Crown Laboratories, Inc.'s Announces Leadership Team Growthhttps://modernaesthetics.com/news/crown-laboratories-incs-annouces-leadership-team-growth/2473256/Joe Proctor and Michael McKenna are stepping into new roles at Crown Laboratories. Joe Proctor will transition from General Manager, Aesthetics into the Head of Innovation and Corporate Development for Crown Aesthetics. Mr. Proctor is the founder of Crown
- Top-line Phase 3 Data Promising for Galderma's RelabotulinumtoxinAhttps://modernaesthetics.com/news/top-line-phase-3-data-promising-for-galdermas-relabotulinumtoxina/2473250/Galderma’s investigational RelabotulinumtoxinA, a novel liquid formulation botulinum toxin A, improves both glabellar and lateral canthal lines with a rapid onset of action and a long duration up to six months, according to top-line phase 3 data presen
- Dr. Paul M. Friedman Named New ASLMS Presidenthttps://modernaesthetics.com/news/dr-paul-m-friedman-named-new-aslms-president/2473244/Paul M. Friedman, MD is the new President of the American Society for Laser Medicine and Surgery (ASLMS). Dr. Friedman, board-certified by the American Board of Dermatology, is the director of Dermatology & Laser Surgery Center of Houston
- R2 Technologies Ships 100 GLACIAL Deviceshttps://modernaesthetics.com/news/r2-technologies-ships-100-glacial-devices/2473224/R2 Technologies Inc. has shipped 100 GLACIAL Rx devices across the globe. To-date customers have delivered more than 15,000 GLACIAL treatment cycles, helping patients reach their skin goals by reducing inflammation and revealing younger looking skin. R2 reached this mileston
- Galderma Launches Alastin Skincare® ReFORM & RePAIR COMPLEXhttps://modernaesthetics.com/news/galderma-launches-alastin-skincare-reform-repair-complex/2473199/Galderma has launched Alastin Skincare® ReFORM & RePAIR COMPLEX with TriHex Technology®. Designed to be used pre- and post-surgery to create an optimal environment for recovery, ReFORM & RePAIR COMPLEX with TriHex Technology® aims to help accelerate the recovery proc
- Crown Laboratories Joins Global Movement to Increase Accurate Media Portrayals of Women and Girlshttps://modernaesthetics.com/news/crown-laboratories-joins-global-movement-to-increase-accurate-media-portrayals-of-women-and-girls/2473186/Crown Laboratories, Inc. is joining SeeHer, a movement to increase accurate portrayals of women and girls in advertising and media, In partnership with the SeeHer movement and via its membership with the Association of National Advertisers, Crown will work to further promote t
- Sculptra Gets New Labelhttps://modernaesthetics.com/news/sculptra-gets-new-label/2473175/A new FDA-approved label for Sculptra® (injectable poly-L-lactic acid (PLLA)) from Galderma includes higher dilution, the addition of immediate use reconstitution, new injection techniques, and the optional addition of lidocaine. Sculptra is the first and only FDA-approved PLLA facial in
- Done Deal: RoundTable Healthcare Partners Completes Sale of Revision Skincare and Goodier Cosmetics to Gryphon Investorshttps://modernaesthetics.com/news/done-deal-roundtable-healthcare-partners-completes-sale-of-revision-skincare-and-goodier-cosmetics-to-gryphon-investors/2473172/RoundTable Healthcare Partners completed the previously announced sale of Revision Skincare and Goodier Cosmetics to Gryphon Investors. Terms of the transaction were not disclosed. Revision Skincare’s portfolio includes Nectifirm, Intellishade, D·E·J